Business
FG extends deadline for registration of online money lenders
The Federal Competition and Consumer Protection Commission (FCCPC) has announced the extension of the deadline for the registration of online money lenders to March 27, 2023.
The Chief Executive Officer of the commission, Babatunde Irukera disclosed this in a statement on its website.
Irukera stated that the extra time was to ensure the registration of Digital Money Lenders whose registration was still in process and to prevent significant market disruptions.
It is the third time the commission has delayed the registration deadline since enforcing mandatory registration in August 2022.
READ ALSO: FCCPC to strengthen operations in 2023, apply more penalties
The statement read, “On December 6, 2022, in furtherance of the collaboration of the Inter-Agency Joint Task Force, the Federal Competition and Consumer Protection Commission extended the deadline for the registration of Digital Money Lenders to January 31, 2023.
“This was to ensure the registration of DMLs whose registration was still in process and to prevent significant market disruptions.
“The Commission noted, however, that several DMLs have not yet provided all relevant documentation to complete their registration process.
“To this end, the Commission is further extending the registration deadline to Monday, March 27, 2023.”
-
Features7 days agoHow ADC leadership crisis put Atiku’s 2027 ambition at risk
-
Energy7 days agoNNPC plans 5–10% stock market listing, targets 2027 for IPO preparations
-
Business7 days agoLoveWorld Expo 2026 to showcase global innovations, emerging technologies in Lagos
-
Business4 days agoDisCos urge Minister to end blame game, apologise to Nigerians over blackouts
-
Latest7 days ago2027: No Court rulings can keep me off the ballot, Atiku insists
-
Latest1 week ago2027: Wike declares Obi’s political wave dead, dismisses chances of presidential victory
-
Latest1 week agoNDC faults Tinubu’s $7.7bn external loan request, raises debt concerns
-
Health5 days agoStudy links Pfizer COVID-19 vaccine to higher death rates than Moderna shot


